International Meeting of the Society for Cardiac Robotic Navigation to Showcase Stereotaxis Technology and Its Clinical Value
29 sept. 2022 09h07 HE
|
Stereotaxis, Inc.
ST. LOUIS, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced its...
Overland Park Regional Medical Center Extends Leadership in Robotic Treatment of Heart Rhythm Disorders with Plans for Second Stereotaxis System
13 sept. 2022 09h06 HE
|
Stereotaxis, Inc.
ST. LOUIS, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that...
Stereotaxis Reports 2022 Second Quarter Financial Results
09 août 2022 09h00 HE
|
Stereotaxis, Inc.
ST. LOUIS, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...
Industry Veterans Join Stereotaxis Commercial Leadership Team as Company Advances Robust Innovation Pipeline
02 août 2022 09h06 HE
|
Stereotaxis, Inc.
ST. LOUIS, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the...
Stereotaxis to Report Second Quarter Financial Results on August 9, 2022
19 juil. 2022 09h00 HE
|
Stereotaxis, Inc.
ST. LOUIS, July 19, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...
Stereotaxis Announces CE Mark Submission for Robotically Navigated MAGiC Ablation Catheter
11 juil. 2022 09h08 HE
|
Stereotaxis, Inc.
ST. LOUIS, July 11, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the CE Mark...
Journal of Atrial Fibrillation & Electrophysiology Publishes Special Issue Dedicated to Robotics in EP
06 juin 2022 09h07 HE
|
Stereotaxis, Inc.
ST. LOUIS, June 06, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announces the publication of a...
Stereotaxis Reports 2022 First Quarter Financial Results
10 mai 2022 09h00 HE
|
Stereotaxis, Inc.
ST. LOUIS, May 10, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...
Heart Centre Rigshospitalet Copenhagen Celebrates 5,000 Robotic Cardiac Ablation Procedures
04 mai 2022 09h07 HE
|
Stereotaxis, Inc.
ST. LOUIS, May 04, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, celebrates the achievements of...
Stereotaxis to Report First Quarter Financial Results on May 10, 2022
14 avr. 2022 09h00 HE
|
Stereotaxis, Inc.
ST. LOUIS, April 14, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it...